Innoviva (INVA) EBT Margin Growth (5y) (2016 - 2026)
Innoviva (INVA) EBT Margin Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -506,399.00 |
| Mar 31, 2026 | -800,465.00 |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | -1,249.00 |
| Jun 30, 2025 | -7,722.00 |
| Mar 31, 2025 | -16,414.00 |
| Dec 31, 2024 | -1.61 Mn |
| Sep 30, 2024 | -8,286.00 |
| Jun 30, 2024 | -12,744.00 |
| Mar 31, 2024 | 172,136.00 |
| Dec 31, 2023 | -75,769.00 |
| Sep 30, 2023 | -2,217.00 |
| Jun 30, 2023 | 12,095.00 |
| Mar 31, 2023 | 216,949.00 |
| Dec 31, 2022 | -156,140.00 |
| Sep 30, 2022 | 7,047.00 |
| Jun 30, 2022 | 43,755.00 |
| Mar 31, 2022 | 196,831.00 |
| Dec 31, 2021 | -460,305.00 |
| Sep 30, 2021 | 9,184.00 |